Roche Holding AG (OTCMKTS:RHHBY) Given Average Recommendation of "Moderate Buy" by Analysts

Key Points

• Roche Holding AG has received a consensus recommendation of "Moderate Buy" from seven brokerages, with varying ratings including one sell, three holds, one buy, and two strong buys.
• HSBC Global Research has downgraded Roche's stock rating from "strong-buy" to "hold," reflecting a change in their outlook on the company's performance.
• Shares of Roche opened at $38.62, with a 1-year low of $34.10 and a high of $44.31, indicating volatility in its stock price over the past year.

Shares of Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) have been given an average rating of "Moderate Buy" by the seven analysts that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, one has given a buy rating and two have assigned a strong buy rating to the company.

A number of brokerages have recently commented on RHHBY. Hsbc Global Res downgraded Roche from a "strong-buy" rating to a "hold" rating in a research report on Monday, April 28th. HSBC cut Roche from a "buy" rating to a "hold" rating in a research report on Monday, April 28th.

Roche Stock Performance

Shares of OTCMKTS RHHBY traded up $0.56 during trading hours on Friday, reaching $38.13. The stock had a trading volume of 891,597 shares, compared to its average volume of 2,334,551. The company has a quick ratio of 1.20, a current ratio of 1.48 and a debt-to-equity ratio of 0.85. Roche has a fifty-two week low of $34.10 and a fifty-two week high of $44.31. The firm has a 50-day moving average of $40.23 and a 200-day moving average of $40.27.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in RHHBY. Accent Capital Management LLC bought a new stake in Roche in the first quarter valued at approximately $35,000. First Horizon Advisors Inc. grew its position in shares of Roche by 81.2% in the second quarter. First Horizon Advisors Inc. now owns 1,843 shares of the company's stock valued at $75,000 after purchasing an additional 826 shares during the last quarter. Atlas Capital Advisors Inc. acquired a new stake in Roche in the 1st quarter worth about $140,000. FineMark National Bank & Trust bought a new stake in shares of Roche during the 2nd quarter worth $210,000. Finally, Beck Mack & Oliver LLC acquired a new position in Roche during the first quarter worth about $232,000.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.